NCT05106491View on ClinicalTrials.gov

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Cardiogenic ShockExtracorporeal Membrane OxygenationECLSVA ECMO
Interventions
DEVICE

Synchronized Cardiac Support with the icor kit

Patients with cardiogenic shock, requiring a venoarterial extracorporeal membrane oxygenation (VA ECMO) for cardiocirculatory stabilization will be treated with Synchronized Cardiac Support (SCS).

Trial Locations (2)

21244

Krankenhaus Buchholz und Winsen gGmbH, Buchholz

45138

Elisabeth-Krankenhaus Essen GmbH, Essen

All Listed Sponsors
lead

Xenios AG

INDUSTRY

NCT05106491 - Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients | Biotech Hunter | Biotech Hunter